Delivery Order SPE2DB20D1109-SPE2DB25FP25F
Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13.3K delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for RINVOQ ER 15 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $42,803.83 for RINVOQ ER 15 mg tablets (30-count units) on May 6, 2025, with completion scheduled for May 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count unit dose) valued at $3,111.66 under a firm fixed-price contract. The award, announced on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,867.74 for RINVOQ ER 15 MG tablets (30-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price contract was competitively awarded without a set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other autoimmune conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $8,396.70 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order valued at $19,029.90 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal medical procurement needs. The delivery order is scheduled for completion by August 4, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. RINVOQ is...
- The Defense Logistics Agency awarded a delivery order valued at $54,355.68 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets in quantities of 30 units, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a prescription medication used in the treatment of rheumatoid arthritis and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $3,700.62 delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose packages). The contract represents a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 18, 2025. This award was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,198.54 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-tablet units). This contract was competitively awarded without set-aside provisions under a firm fixed-price structure, with an ultimate completion date of June 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. RINVOQ (upadacitinib) is a JAK inhibitor used for treating...
- The Defense Logistics Agency awarded a $16.1K delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on September 11, 2025, with completion scheduled for September 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be performed at AmerisourceBergen's...